Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

<strong>Background:</strong> The World Health Organization (WHO) has identified the need for a better understanding of which patients with hepatitis C virus (HCV) can be cured with ultrashort course HCV therapy. <br> <strong>Methods:</strong> A total of 202 individuals...

Full description

Bibliographic Details
Main Authors: Cooke, GS, Pett, S, McCabe, L, Jones, C, Gilson, R, Verma, S, Ryder, SD, Collier, JD, Barclay, ST, Ala, A, Bhagani, S, Nelson, M, Ch'Ng, C, Stone, B, Wiselka, M, Forton, D, McPherson, S, Halford, R, Nguyen, D, Smith, D, Ansari, A, Dennis, E, Hudson, F, Barnes, EJ, Walker, AS
Format: Journal article
Language:English
Published: F1000Research 2021

Similar Items